MetLife Investment Management’s Invesco IVZ Stock Holding History

MetLife Investment Management’s Portfolio IVZ Stock Details IVZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.49M	Sell	102,430 -2,938	-3%	-$76.9K	0.01%	944
2025 Q4	$2.77M	Sell	105,368 -3,912	-4%	-$95.6K	0.01%	910
2025 Q3	$2.51M	Sell	109,280 -3,362	-3%	-$69.8K	0.01%	987
2025 Q2	$1.78M	Sell	112,642 -2,225	-2%	-$32K	0.01%	1053
2025 Q1	$1.74M	Sell	114,867 -2,610	-2%	-$44.5K	0.01%	1107
2024 Q4	$2.05M	Buy	117,477 +1,952	+2%	+$34.8K	0.01%	1021
2024 Q3	$2.03M	Sell	115,525 -2,940	-2%	-$48.3K	0.01%	1006
2024 Q2	$1.77M	Buy	118,465 +14,909	+14%	+$229K	0.01%	1032
2024 Q1	$1.72M	Sell	103,556 -3,887	-4%	-$62.7K	0.01%	1028
2023 Q4	$1.92M	Sell	107,443 -1,817	-2%	-$26.2K	0.01%	966
2023 Q3	$1.59M	Sell	109,260 -5,295	-5%	-$85.2K	0.01%	1008
2023 Q2	$1.93M	Sell	114,555 -1,122	-1%	-$18.1K	0.01%	942
2023 Q1	$1.9M	Sell	115,677 -1,409	-1%	-$25.1K	0.01%	929
2022 Q4	$2.11M	Sell	117,086 -1,977	-2%	-$33.8K	0.02%	875
2022 Q3	$1.63M	Buy	119,063 +27,587	+30%	+$465K	0.01%	966
2022 Q2	$1.48M	Sell	91,476 -1,225	-1%	-$23.2K	0.01%	1029
2022 Q1	$2.14M	Buy	92,701 +17,296	+23%	+$384K	0.01%	965
2021 Q4	$1.74M	Sell	75,405 -1,709	-2%	-$41.6K	0.01%	915
2021 Q3	$1.86M	Sell	77,114 -10,613	-12%	-$265K	0.02%	889
2021 Q2	$2.34M	Sell	87,727 -1,978	-2%	-$53.9K	0.02%	809
2021 Q1	$2.26M	Sell	89,705 -1,767	-2%	-$39.6K	0.02%	820
2020 Q4	$1.59M	Sell	91,472 -3,991	-4%	-$61.4K	0.02%	926
2020 Q3	$1.09M	Sell	95,463 -2,951	-3%	-$31.3K	0.01%	990
2020 Q2	$1.06M	Buy	98,414 +2,477	+3%	+$22.2K	0.01%	1009
2020 Q1	$871K	Sell	95,937 -2,935	-3%	-$44.6K	0.01%	965
2019 Q4	$1.78M	Sell	98,872 -5,963	-6%	-$102K	0.02%	853
2019 Q3	$1.78M	Sell	104,835 -5,581	-5%	-$98.5K	0.02%	836
2019 Q2	$2.26M	Sell	110,416 -2,466	-2%	-$51.2K	0.02%	757
2019 Q1	$2.18M	Sell	112,882 -4,743	-4%	-$88.7K	0.02%	780
2018 Q4	$1.97M	Sell	117,625 -1,884	-2%	-$37.7K	0.02%	760
2018 Q3	$2.73M	Buy	+119,509	New	+$2.99M	0.03%	714

Other funds holding IVZ

MMLI

Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MetLife Investment Management's IVZ Position: Q1 2026 in Review

MetLife Investment Management reduced its Invesco (IVZ) stake by 2.8% in Q1 2026, selling an estimated $76.9K and leaving 102,430 shares worth $2.49M. The position accounts for 0.01% of the portfolio, ranked #944.

MetLife Investment Management first reported a position in IVZ in Q3 2018 and has held it in 31 quarters since. The position peaked at $2.77M in Q4 2025. 631 funds tracked by Wall St. Rank hold IVZ as of Q1 2026.

MetLife Investment Management held 102,430 shares of Invesco worth $2.49M as of Q1 2026.
MetLife Investment Management sold 2,938 Invesco shares in Q1 2026, an estimated $76.9K.
Invesco made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #944 holding.
MetLife Investment Management first reported a position in Invesco in Q3 2018 and has held it in 31 quarters since.
MetLife Investment Management's Invesco position peaked at $2.77M in Q4 2025.
631 funds tracked by Wall St. Rank held Invesco as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.